Description

Phenylpropanol is a sympathomimetic agent that stimulates alpha- and beta-adrenergic receptors, causing vasoconstriction and bronchodilation. It is widely studied in research models targeting nasal congestion, hypotension, and urinary incontinence. The soft capsule format ensures controlled oral delivery and accurate dosing in pharmacodynamic experiments.

Phenylpropanol Soft Capsules Product Specifications

Phenylpropanol Soft Capsules Mechanism of Action

Phenylpropanol acts as a sympathomimetic by activating alpha-adrenergic receptors to induce vasoconstriction (reducing nasal congestion) and ?-adrenergic receptors to induce mild bronchodilation and increase cardiac output—useful in pharmacodynamic research models.

Phenylpropanol Soft Capsules Research Application Areas

• Nasal decongestion and vascular permeability studies

• Hypotension and blood pressure modulation testing

• Urinary incontinence and smooth muscle activity models

• Adrenergic receptor-mediated pharmacological research

• Comparative studies with phenylephrine or pseudoephedrine

Safety & Handling

• Side Effects: Increased heart rate, elevated blood pressure, restlessness, and insomnia.

• Contraindications: Avoid in subjects with hypertension, heart disease, or hyperthyroidism.

• Handling: Use gloves, lab coat, eye protection. Avoid ingestion outside controlled studies.

• Storage: Store sealed and protected from heat, moisture, light.

Core Keywords

phenylpropanol capsules, phenylpropanol 100mg, CAS 1335-12-2, H42021959, sympathomimetic research capsule, nasal decongestant model compound, vascular constrictor agent, wholesale phenylpropanol soft caps

Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. It is not approved for clinical, therapeutic, diagnostic, or veterinary applications. Use only under institutional protocols and approved safety guidelines.